Filtered By:
Countries: Iran Health
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 32769 results found since Jan 2013.
Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Non-diabetic Chronic Kidney Disease: A Systematic Review
Iran J Kidney Dis. 2023 Jul;17(4):175-183.ABSTRACTSodium-glucose cotransporter-2 (SGLT2) inhibitors modulate kidney function in diabetic chronic kidney disease trials. Furthermore, recent studies have showed their effect on kidney dysfunction in non-diabetic chronic kidney disease (CKD). Here, we focus on the impact of SGLT2 inhibitors on some renal parameters in nondiabetic CKD by discussing completed and ongoing trials. Different databases and search engines of Web of Science, PubMed, Google Scholar, Scopus, SID, and Magiran were searched until November 2022. We included human studies that evaluated the effect of SGLT2 i...
Source: Iranian Journal of Kidney Diseases - August 27, 2023 Category: Urology & Nephrology Authors: Nakisa Rasaei Leila Malekmakan Ghazal Gholamabbas Mina Mashayekh Farshad Hadianfard Mahsa Torabi Source Type: research
Correlation Between Serum Homocysteine Levels and Carotid Intima-media Thickening in Hemodialysis Patients
CONCLUSION: The results of the study suggest that there is no relationship between serum homocysteine level and carotid intima-media thickness in hemodialysis patients. DOI: 10.52547/ijkd.7424.PMID:37634249
Source: Atherosclerosis - August 27, 2023 Category: Cardiology Authors: Alireza Soleimani Seyed Hamed Tabatabaei Maryam Soleimani Mehrdad Sinaeinejad Fereshteh Ghazvini Seyed Zia Tabatabaei Hossein Mofidi Mehdi Kashani Seyyed Taher Seyyed Mahmoudi Source Type: research
Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Non-diabetic Chronic Kidney Disease: A Systematic Review
Iran J Kidney Dis. 2023 Jul;17(4):175-183.ABSTRACTSodium-glucose cotransporter-2 (SGLT2) inhibitors modulate kidney function in diabetic chronic kidney disease trials. Furthermore, recent studies have showed their effect on kidney dysfunction in non-diabetic chronic kidney disease (CKD). Here, we focus on the impact of SGLT2 inhibitors on some renal parameters in nondiabetic CKD by discussing completed and ongoing trials. Different databases and search engines of Web of Science, PubMed, Google Scholar, Scopus, SID, and Magiran were searched until November 2022. We included human studies that evaluated the effect of SGLT2 i...
Source: Iranian Journal of Kidney Diseases - August 27, 2023 Category: Urology & Nephrology Authors: Nakisa Rasaei Leila Malekmakan Ghazal Gholamabbas Mina Mashayekh Farshad Hadianfard Mahsa Torabi Source Type: research
Prediction of water quality under the impacts of fine dust and sand storm events using an experimental model and multivariate regression analysis
Environ Pollut. 2023 Aug 25:122462. doi: 10.1016/j.envpol.2023.122462. Online ahead of print.ABSTRACTMany regions of the world, especially arid and semiarid areas, occasionally experience fine dust and sandstorms, known environmental problems that make normal life difficult. Since the intrusion of large amounts of dust into treatment plants may significantly change the water quality indices, the main goal of this study was to estimate these indices during the events, which can help decision-makers to improve water quality. To achieve relationships using nonlinear multivariate regression analysis, a long-term (three years: ...
Source: Environmental Pollution - August 27, 2023 Category: Environmental Health Authors: Majid Galoie Artemis Motamedi Jihui Fan Mahdi Moudi Source Type: research
Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Non-diabetic Chronic Kidney Disease: A Systematic Review
Iran J Kidney Dis. 2023 Jul;17(4):175-183.ABSTRACTSodium-glucose cotransporter-2 (SGLT2) inhibitors modulate kidney function in diabetic chronic kidney disease trials. Furthermore, recent studies have showed their effect on kidney dysfunction in non-diabetic chronic kidney disease (CKD). Here, we focus on the impact of SGLT2 inhibitors on some renal parameters in nondiabetic CKD by discussing completed and ongoing trials. Different databases and search engines of Web of Science, PubMed, Google Scholar, Scopus, SID, and Magiran were searched until November 2022. We included human studies that evaluated the effect of SGLT2 i...
Source: Iranian Journal of Kidney Diseases - August 27, 2023 Category: Urology & Nephrology Authors: Nakisa Rasaei Leila Malekmakan Ghazal Gholamabbas Mina Mashayekh Farshad Hadianfard Mahsa Torabi Source Type: research
